Journal of the American Academy of Dermatology
Volume 42, Issue 6 , Pages 1026-1029 , June 2000

Botulinum toxin type A therapy for palmar and digital hyperhidrosis

References 

  1. Byrne J, Walsh TN, Hederman WP. Endoscopic transthoracic electrocautery of the sympathetic chain for palmar and axillary hyperhidrosis. Br J Surg. 1990;77:1046–1049
  2. Shelley WB, Florence R. Compensatory hyperhidrosis after sympathectomy. N Engl J Med. 1960;263:1056–1058
  3. Gillespie JA. Extent and permanence of denervation produced by lumbar sympathectomy. Br Med J. 1961;1:79–83
  4. Quinn AC, Edwards RE, Newman PJ, Fawcett WJ. Complications of endoscopic sympathectomy. Br Med J. 1993;306:1752
  5. Shelley WB, Talanin NY, Shelley ED. Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol. 1998;38:227–229
  6. Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol. 1998;134:301–304
  7. Holmes S, Mann C. Botulinum toxin in the treatment of palmar hyperhidrosis [letter]. J Am Acad Dermatol. 1998;39:1040–1041
  8. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis: no sweat Botox. Dermatol Surg. 1998;24:817–819
  9. Odderson Ib R. Hyperhidrosis treated by botulinum A exotoxin. Dermatol Surg. 1998;24:1237–1241
  10. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol. 1997;136:548–552
  11. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol. 1996;34:788–797
  12. Bushara KO, Park DM, Jones JC, Schutta HS. Botulinum toxin: a possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol. 1996;21:276–278
  13. Scott AB. Foreword. In:  Jankovic J,  Hallet M editor. Therapy with botulinum toxin. New York: Marcel Dekker; 1994;p. vii–ix
  14. Ambache N. A further study of the action of Clostridium botulinum toxin upon different types of autonomic nerve fibre. J Physiol. 1951;113:1–17
  15. Heckmann M, Schaller M, Plewig G, Ceballos-Baumann A. Optimizing botulinum toxin therapy for hyperhidrosis [letter]. Br J Dermatol. 1998;138:553–554
  16. Goschel H, Wohlfarth K, Frevert J, Denger R, Bigalke H. Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies-therapeutic consequences. Exp Neurol. 1997;147:96–102
  17. Product monograph: Botox (botulinum toxin type A) purified neurotoxin complex. Irvine (CA): Allergan, Inc; 1997;
  18. Cox NH, Duffey P, Royle J. Fixed drug eruption caused by lactose in an injected botulinum toxin preparation. J Am Acad Dermatol. 1999;40:263–264
  19. Botox (botulinum toxin type A) purified neurotoxin complex [package insert]. Irvine (CA): Allergan, Inc; 1995; Data on file

☆ Supported by a grant from Allergan, Inc.

☆☆ Reprint requests: Barry A. Solomon, MD, JD, 222 Middle Country Rd, Suite 228, Smithtown, NY 11787.

★ J Am Acad Dermatol 2000;42:1026–9

PII: S0190-9622(00)90298-6

doi: 10.1016/S0190-9622(00)90298-6

Journal of the American Academy of Dermatology
Volume 42, Issue 6 , Pages 1026-1029 , June 2000

Article Tools

* Image Usage & Resolution